Strong Evidence Base HelloBetter's leadership in digital therapeutics is supported by the strongest evidence in the industry, with 33 peer-reviewed randomized controlled trials. This robust research foundation enhances credibility and market trust, presenting a compelling selling point to healthcare providers and insurers seeking evidence-based solutions.

Expanding Market Presence The company's recent entry into the US market with the HelloGina brand and launch of the Mein MentalHealthCoach partnership demonstrate significant growth and international expansion, offering opportunities to establish collaborations in diverse healthcare systems and corporate wellness programs.

Strong Funding Support With over €31 million in combined funding—including major investments from Mutuelles Impact and HSBC—HelloBetter is well-positioned for product development, market expansion, and strategic partnerships, making it an attractive partner for institutions looking to innovate in mental health care.